Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$339,612
-$13,240 QoQ
Shares Held
2,167
-6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,065
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caldwell Trust Co holds $66,282,067 across 15 Drug Manufacturers - General names. NVS ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,550 | $25,847,718 | |
| 2 | JNJ |
Johnson & Johnson
|
56,485 | $14,345,495 | |
| 3 | AMGN |
Amgen Inc
|
26,584 | $9,626,598 | |
| 4 | ABBV |
AbbVie Inc.
|
27,070 | $6,811,894 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,474 | $4,558,408 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
30,189 | $1,739,490 | |
| 7 | AZN |
Astrazeneca PLC
|
8,454 | $1,603,047 | |
| 8 | PFE |
Pfizer Inc
|
44,139 | $1,062,867 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,612 | 2,167 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $352,852 | 2,310 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $318,479 | 2,310 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $375,486 | 2,928 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $378,398 | 3,127 | Shares | Sole | 2025-09-22 | |
| 2025-03-31 | $364,205 | 3,267 | Shares | Sole | 2025-09-23 | |
| 2024-12-31 | $324,042 | 3,330 | Shares | Sole | 2025-09-24 | |
| 2024-09-30 | $383,016 | 3,330 | Shares | Sole | 2025-09-24 | |
| 2024-06-30 | $354,511 | 3,330 | Shares | Sole | 2025-09-24 | |
| 2024-03-31 | $331,783 | 3,430 | Shares | Sole | 2025-09-24 | |
| 2023-12-31 | $346,327 | 3,430 | Shares | Sole | 2025-10-01 | |
| 2023-09-30 | $382,484 | 3,755 | Shares | Sole | 2025-10-01 | |
| 2023-06-30 | $378,917 | 3,755 | Shares | Sole | 2025-10-01 | |
| 2023-03-31 | $345,460 | 3,755 | Shares | Sole | 2025-10-01 | |
| 2022-12-31 | $363,333 | 4,005 | Shares | Sole | 2025-10-01 | |
| 2022-09-30 | $392,971 | 5,170 | Shares | Sole | 2025-10-01 | |
| 2022-06-30 | $437,104 | 5,171 | Shares | Sole | 2025-10-02 | |
| 2022-03-31 | $476,131 | 5,426 | Shares | Sole | 2025-10-02 | |
| 2021-12-31 | $485,720 | 5,553 | Shares | Sole | 2025-10-02 | |
| 2021-09-30 | $495,668 | 6,061 | Shares | Sole | 2025-10-02 | |
| 2021-06-30 | $564,958 | 6,192 | Shares | Sole | 2025-10-02 | |
| 2021-03-31 | $548,952 | 6,422 | Shares | Sole | 2025-10-02 | |
| 2020-12-31 | $662,898 | 7,020 | Shares | Sole | 2025-10-02 | |
| 2020-09-30 | $622,981 | 7,164 | Shares | Sole | 2025-10-02 | |
| 2020-06-30 | $644,918 | 7,384 | Shares | Sole | 2025-10-02 | |
| 2020-03-31 | $627,362 | 7,609 | Shares | Sole | 2025-10-02 | |
| No filing history on record for this holder in this stock. | ||||||